Role of environmental toxicants in modulating disease severity in children with NAFLD (Q43): Difference between revisions
Changed an Item |
Changed an Item |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / geographic location | |||
| Property / geographic location: Missouri, United States of America / rank | |||
Normal rank | |||
| Property / participant life stages | |||
| Property / participant life stages: Adolescence / rank | |||
Normal rank | |||
| Property / primary health outcomes | |||
| Property / primary health outcomes: liver disease / rank | |||
Normal rank | |||
| Property / parent study grant number | |||
NIH-1U01-DK61718 | |||
| Property / parent study grant number: NIH-1U01-DK61718 / rank | |||
Normal rank | |||
Latest revision as of 00:07, 20 December 2024
Nonalcoholic fatty liver disease (NAFLD) is a global health problem, with prevalence estimated at 20% to 30% of the general population. There is not a good understanding of why some children progress to severe disease more rapidly. While it has been
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Role of environmental toxicants in modulating disease severity in children with NAFLD |
Nonalcoholic fatty liver disease (NAFLD) is a global health problem, with prevalence estimated at 20% to 30% of the general population. There is not a good understanding of why some children progress to severe disease more rapidly. While it has been |
Statements
Jain, Ajay
0 references
The National Exposure Assessment Laboratory at Emory
0 references
2017-1593
0 references
St. Louis, Chicago,Cincinnati, New York City, Atlanta, Indianoplis, Texas ( Tx Childrens hospital), San Diego, San Francisco, Seattle
0 references
600
0 references
Role of environmental toxicants in modulating disease severity in children with NAFLD
0 references
NIH-1U01-DK61718
0 references